REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > 1-thia-4-aza-bicyclo (3.2.0) Heptane Ring Containing (including Dehydrogenated) (e.g., Penicillins, Etc.) > 6-position Substituent Contains Carbocyclic Ring > 1-thia-5-aza-bicyclo (4.2.0) Octane Ring Containing (including Dehydrogenated) (e.g., Cephalosporins, Etc.) 1-thia-5-aza-bicyclo (4.2.0) Octane Ring Containing (including Dehydrogenated) (e.g., Cephalosporins, Etc.)1-thia-5-aza-bicyclo (4.2.0) Octane Ring Containing (including Dehydrogenated) (e.g., Cephalosporins, Etc.) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/25/07 - 20070021402 - Novel oral pharmaceutical suspension of cefdinir crystal The present invention relates to a novel oral pharmaceutical suspension of Cefdinir crystal. More specifically, the present invention relates to a novel kit for preparation of an oral pharmaceutical suspension containing crystal form C Cefdinir. ... 09/21/06 - 20060211676 - Crystalline anhydrous cefdinir and crystalline cefdinir hydrates A novel crystalline cefdinir anhydrate and novel crystalline cefdinir hydrates, ways to make them and use them, compositions comprising them and made with them, and methods of treatment using them are disclosed. ... 08/10/06 - 20060178357 - Chphalosporin-derived mercaptans as inhibitors of serine and metallo-beta-lactamases wherein R1, R2, R3, R4 and n have any of the values defined in the specification, and their pharmaceutically acceptable salts, are useful for inhibiting simultaneously serine and metallo-β-lactamase enzymes, for enhancing the activity of β-lactam antibiotics, and for treating β-lactam resistant bacterial infections in a mammal. The invention also ... 04/06/06 - 20060074066 - Use of an inhibitor of cathepsin-s or -b to treat or prevent chronic obstructive pulmonary disease This invention is directed to the use of an inhibitor of cathepsin-S or -B, or composition thereof, to treat or prevent chronic obstruction pulmonary disease, or physiological condition associated therewith. Such a therapy would occur using at least one of such inhibitors alone or in combination with the other, or ... 04/06/06 - 20060074065 - 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors wherein: R1—R4 and A have any of the values defined in the specification, and their pharmaceutically acceptable salts, are useful for inhibiting β-lactamase enzymes, for enhancing the activity of β-lactam antibiotics, and for treating β-lactam resistant bacterial infections in a mammal. The invention also provides pharmaceutical compositions, processes for preparing ... 11/24/05 - 20050261268 - Aminotriazole compounds useful as inhibitors of protein kinases The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention, processes for preparing the compounds and methods of using the compositions in the treatment of various disorders. ... ### FreshPatents.com Support |